Last 12 months
Inside the activity.
1 purchase rows · 23 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 13 |
| Mar 2026 | 1 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2021 Filed Jun 12, 2021 00:07 UTC |
Houston John GDirector · President and CEO
|
SaleCommon Stock | 14,487 | $82.46 | $1,194,531.38 |
DisclosureSEC source: 0000899243-21-023375 · doc4.xml · nonDerivative · entry 6 Houston John G · CIK 0001753537 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 827,643 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020. F6 · price: The price reported in this Column 4 is a weighed average price. These shares were sold in multiple transactions at prices ranging from $82.0800 to $82.7600, inclusive. The reporting person undertakes to provide to Arvinas, Inc., any security holder of Arvinas, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (6). Read SEC document |
| June 10, 2021 Filed Jun 12, 2021 00:07 UTC |
Houston John GDirector · President and CEO
|
SaleCommon Stock | 11,784 | $81.75 | $963,375.00 |
DisclosureSEC source: 0000899243-21-023375 · doc4.xml · nonDerivative · entry 5 Houston John G · CIK 0001753537 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 842,130 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.0800 to $82.0750, inclusive. The reporting person undertakes to provide to Arvinas, Inc., any security holder of Arvinas, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price range within the range set forth in this footnote (5). Read SEC document |
| June 10, 2021 Filed Jun 12, 2021 00:07 UTC |
Houston John GDirector · President and CEO
|
SaleCommon Stock | 17,615 | $80.52 | $1,418,356.28 |
DisclosureSEC source: 0000899243-21-023375 · doc4.xml · nonDerivative · entry 4 Houston John G · CIK 0001753537 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 853,914 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.0000 to $80.9400, inclusive. The reporting person undertakes to provide to Arvinas, Inc., any security holder of Arvinas, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4). Read SEC document |
| June 10, 2021 Filed Jun 12, 2021 00:07 UTC |
Houston John GDirector · President and CEO
|
Exercise / conversionCommon Stock | 43,886 | $16.00 | $702,176.00 |
DisclosureSEC source: 0000899243-21-023375 · doc4.xml · nonDerivative · entry 3 Houston John G · CIK 0001753537 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 871,529 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 30, 2020. Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:07 UTC |
Houston John GDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 700 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-21-023375 · doc4.xml · derivative · entry 7 Houston John G · CIK 0001753537 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,620 Underlying: Common Stock · 700 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 30, 2020. F7 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested on March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022. Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:07 UTC |
Houston John GDirector · President and CEO
|
SaleCommon Stock | 700 | $80.15 | $56,103.53 |
DisclosureSEC source: 0000899243-21-023375 · doc4.xml · nonDerivative · entry 2 Houston John G · CIK 0001753537 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 827,643 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.0950 to $80.2150, inclusive. The reporting person undertakes to provide to Arvinas, Inc., any security holder of Arvinas, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price range within the range set forth in this footnote (3). Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:07 UTC |
Houston John GDirector · President and CEO
|
Exercise / conversionCommon Stock | 700 | $16.00 | $11,200.00 |
DisclosureSEC source: 0000899243-21-023375 · doc4.xml · nonDerivative · entry 1 Houston John G · CIK 0001753537 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 828,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 30, 2020. Read SEC document |
| June 08, 2021 Filed Jun 11, 2021 00:00 UTC |
Kennedy Edward Moore Jr.Director
|
GrantStock Option (right to buy) · Derivative | 7,511 | $0.00 Strike: $78.53 | $0.00 |
DisclosureSEC source: 0001209191-21-039674 · doc4.xml · derivative · entry 1 Kennedy Edward Moore Jr. · CIK 0001753859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,511 Underlying: Common Stock · 7,511 shares Expires 2021-06-07 F1 · derivative.exercise_date: This option award was granted on June 8, 2021. The shares underlying the award shall vest in full on June 8, 2022 or, if earlier, the date of the first meeting of the board of directors of the Issuer held after the Issuer's next annual meeting of stockholders. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 20:00 UTC |
SHANNON TIMOTHY MDirector
|
GrantStock Option (right to buy) · Derivative | 7,511 | $0.00 Strike: $78.53 | $0.00 |
DisclosureSEC source: 0001209191-21-039672 · doc4.xml · derivative · entry 1 SHANNON TIMOTHY M · CIK 0001207114 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,511 Underlying: Common Stock · 7,511 shares Expires 2031-06-07 F1 · derivative.exercise_date: This option award was granted on June 8, 2021. The shares underlying the award shall vest in full on June 8, 2022 or, if earlier, the date of the first meeting of the board of directors of the Issuer held after the Issuer's next annual meeting of stockholders. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 20:00 UTC |
DIXON WENDY LDirector
|
GrantStock Option (right to buy) · Derivative | 7,511 | $0.00 Strike: $78.53 | $0.00 |
DisclosureSEC source: 0001209191-21-039671 · doc4.xml · derivative · entry 1 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,511 Underlying: Common Stock · 7,511 shares Expires 2021-06-07 F1 · derivative.exercise_date: This option award was granted on June 8, 2021. The shares underlying the award shall vest in full on June 8, 2022 or, if earlier, the date of the first meeting of the board of directors of the Issuer held after the Issuer's next annual meeting of stockholders. Read SEC document |
| June 08, 2021 Filed Jun 11, 2021 00:00 UTC |
Norwalk Leslie VDirector
|
GrantStock Option (right to buy) · Derivative | 7,511 | $0.00 Strike: $78.53 | $0.00 |
DisclosureSEC source: 0001209191-21-039677 · doc4.xml · derivative · entry 1 Norwalk Leslie V · CIK 0001533568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,511 Underlying: Common Stock · 7,511 shares Expires 2021-06-07 F1 · derivative.exercise_date: This option award was granted on June 8, 2021. The shares underlying the award shall vest in full on June 8, 2022 or, if earlier, the date of the first meeting of the board of directors of the Issuer held after the Issuer's next annual meeting of stockholders. Read SEC document |
| June 08, 2021 Filed Jun 11, 2021 00:00 UTC |
Ratcliffe LiamDirector
|
GrantStock Option (right to buy) · Derivative | 7,511 | $0.00 Strike: $78.53 | $0.00 |
DisclosureSEC source: 0001209191-21-039678 · doc4.xml · derivative · entry 1 Ratcliffe Liam · CIK 0001547100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,511 Underlying: Common Stock · 7,511 shares Expires 2021-06-07 F1 · derivative.exercise_date: This option award was granted on June 8, 2021. The shares underlying the award shall vest in full on June 8, 2022 or, if earlier, the date of the first meeting of the board of directors of the Issuer held after the Issuer's next annual meeting of stockholders. Read SEC document |
| June 08, 2021 Filed Jun 11, 2021 00:00 UTC |
Bain LindaDirector
|
GrantStock Option (right to buy) · Derivative | 7,511 | $0.00 Strike: $78.53 | $0.00 |
DisclosureSEC source: 0001209191-21-039673 · doc4.xml · derivative · entry 1 Bain Linda · CIK 0001578407 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,511 Underlying: Common Stock · 7,511 shares Expires 2021-06-07 F1 · derivative.exercise_date: This option award was granted on June 8, 2021. The shares underlying the award shall vest in full on June 8, 2022 or, if earlier, the date of the first meeting of the board of directors of the Issuer held after the Issuer's next annual meeting of stockholders. Read SEC document |
| June 08, 2021 Filed Jun 11, 2021 00:00 UTC |
Smaldone Alsup LaurieDirector
|
GrantStock Option (right to buy) · Derivative | 7,511 | $0.00 Strike: $78.53 | $0.00 |
DisclosureSEC source: 0001209191-21-039679 · doc4.xml · derivative · entry 1 Smaldone Alsup Laurie · CIK 0001589602 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,511 Underlying: Common Stock · 7,511 shares Expires 2021-06-07 F1 · derivative.exercise_date: This option award was granted on June 8, 2021. The shares underlying the award shall vest in full on June 8, 2022 or, if earlier, the date of the first meeting of the board of directors of the Issuer held after the Issuer's next annual meeting of stockholders. Read SEC document |
| June 08, 2021 Filed Jun 11, 2021 00:00 UTC |
Morrison BriggsDirector
|
GrantStock Option (right to buy) · Derivative | 7,511 | $0.00 Strike: $78.53 | $0.00 |
DisclosureSEC source: 0001209191-21-039675 · doc4.xml · derivative · entry 1 Morrison Briggs · CIK 0001654430 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,511 Underlying: Common Stock · 7,511 shares Expires 2021-06-07 F1 · derivative.exercise_date: This option award was granted on June 8, 2021. The shares underlying the award shall vest in full on June 8, 2022 or, if earlier, the date of the first meeting of the board of directors of the Issuer held after the Issuer's next annual meeting of stockholders. Read SEC document |
| June 08, 2021 Filed Jun 11, 2021 00:00 UTC |
Margus Bradley AlbertDirector
|
GrantStock Option (right to buy) · Derivative | 7,511 | $0.00 Strike: $78.53 | $0.00 |
DisclosureSEC source: 0001209191-21-039676 · doc4.xml · derivative · entry 1 Margus Bradley Albert · CIK 0001753491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,511 Underlying: Common Stock · 7,511 shares Expires 2021-06-07 F1 · derivative.exercise_date: This option award was granted on June 8, 2021. The shares underlying the award shall vest in full on June 8, 2022 or, if earlier, the date of the first meeting of the board of directors of the Issuer held after the Issuer's next annual meeting of stockholders. Read SEC document |
| April 06, 2021 Filed Jan 29, 2022 02:00 UTC |
Kennedy Edward Moore Jr.Director
|
GiftCommon Stock | 29,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-003588 · doc5.xml · nonDerivative · entry 1 Kennedy Edward Moore Jr. · CIK 0001753859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,385 F1 · shares: On April 6, 2021, the reporting person transferred 29,333 shares of the Registrant's common stock to a family trust, for which the reporting person acts as a trustee. Members of the reporting person's immediate family are the sole beneficiaries of the trust. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 18:00 UTC |
Taylor IanChief Scientific Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,789 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-21-025942 · doc4.xml · derivative · entry 6 Taylor Ian · CIK 0001753281 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,601 Underlying: Common Stock · 15,789 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested on June 28, 2019, with the remainder of the shares vesting in equal monthly installments following June 28, 2019 through June 28, 2022. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 18:00 UTC |
Taylor IanChief Scientific Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 9,211 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-21-025942 · doc4.xml · derivative · entry 5 Taylor Ian · CIK 0001753281 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,211 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of June 1, 2017, with the remainder of the shares vesting in equal monthly installments following June 1, 2017 through June 1, 2020. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 18:00 UTC |
Taylor IanChief Scientific Officer
|
SaleCommon Stock | 4,450 | $67.56 | $300,642.00 |
DisclosureSEC source: 0001209191-21-025942 · doc4.xml · nonDerivative · entry 4 Taylor Ian · CIK 0001753281 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,645 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.31 to $68.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 18:00 UTC |
Taylor IanChief Scientific Officer
|
SaleCommon Stock | 16,450 | $66.80 | $1,098,860.00 |
DisclosureSEC source: 0001209191-21-025942 · doc4.xml · nonDerivative · entry 3 Taylor Ian · CIK 0001753281 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,095 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.31 to $67.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 18:00 UTC |
Taylor IanChief Scientific Officer
|
SaleCommon Stock | 4,100 | $66.01 | $270,641.00 |
DisclosureSEC source: 0001209191-21-025942 · doc4.xml · nonDerivative · entry 2 Taylor Ian · CIK 0001753281 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,545 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.30 to $66.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 18:00 UTC |
Taylor IanChief Scientific Officer
|
Exercise / conversionCommon Stock | 25,000 | $16.00 | $400,000.00 |
DisclosureSEC source: 0001209191-21-025942 · doc4.xml · nonDerivative · entry 1 Taylor Ian · CIK 0001753281 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2021 Filed Mar 2, 2021 21:04 UTC |
Taylor IanChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,685 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009202 · doc4.xml · derivative · entry 4 Taylor Ian · CIK 0001753281 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,371 Underlying: Common Stock · 2,685 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: On March 1, 2019, the reporting person was granted 10,742 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020. F5 · derivative.expiration_date: On March 1, 2019, the reporting person was granted 10,742 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020. Read SEC document |
| March 02, 2021 Filed Mar 2, 2021 21:04 UTC |
Taylor IanChief Scientific Officer
|
SaleCommon Stock | 894 | $77.45 | $69,239.85 |
DisclosureSEC source: 0000899243-21-009202 · doc4.xml · nonDerivative · entry 2 Taylor Ian · CIK 0001753281 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,645 F2 · shares: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units. F3 · price: The broker sold shares of the Issuer's common stock for certain employees following the vesting of previously granted Restricted Stock Units, including the common stock reported on this Form 4 by the reporting person, at an average price of $77.4495. Read SEC document |
| March 02, 2021 Filed Mar 2, 2021 21:04 UTC |
Taylor IanChief Scientific Officer
|
Exercise / conversionCommon Stock | 2,685 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-009202 · doc4.xml · nonDerivative · entry 1 Taylor Ian · CIK 0001753281 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 02, 2021 Filed Mar 2, 2021 21:02 UTC |
Cassidy Sean AChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,792 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009199 · doc4.xml · derivative · entry 4 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,582 Underlying: Common Stock · 4,792 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: On March 1, 2019, the reporting person was granted 19,165 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020. F5 · derivative.expiration_date: On March 1, 2019, the reporting person was granted 19,165 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020. Read SEC document |
| March 02, 2021 Filed Mar 2, 2021 21:02 UTC |
Cassidy Sean AChief Financial Officer
|
SaleCommon Stock | 2,221 | $77.45 | $172,015.34 |
DisclosureSEC source: 0000899243-21-009199 · doc4.xml · nonDerivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,249 F2 · shares: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units. F3 · price: The broker sold shares of the Issuer's common stock for certain employees following the vesting of previously granted Restricted Stock Units, including the common stock reported on this Form 4 by the reporting person, at an average price of $77.4495. Read SEC document |
| March 02, 2021 Filed Mar 2, 2021 21:02 UTC |
Cassidy Sean AChief Financial Officer
|
Exercise / conversionCommon Stock | 4,792 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-009199 · doc4.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 02:00 UTC |
Houston John GDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 17,510 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009196 · doc4.xml · derivative · entry 7 Houston John G · CIK 0001753537 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,021 Underlying: Common Stock · 17,510 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. F9 · derivative.exercise_date: On March 1, 2019, the reporting person was granted 70,042 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020. F9 · derivative.expiration_date: On March 1, 2019, the reporting person was granted 70,042 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 02:00 UTC |
Houston John GDirector · President and CEO
|
SaleCommon Stock | 8,115 | $77.45 | $628,502.69 |
DisclosureSEC source: 0000899243-21-009196 · doc4.xml · nonDerivative · entry 5 Houston John G · CIK 0001753537 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 827,643 F6 · shares: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units. F7 · price: The broker sold shares of the Issuer's common stock for certain employees following the vesting of previously granted Restricted Stock Units, including the common stock reported on this Form 4 by the reporting person, at an average price of $77.4495. F4 · balance_after: Includes an aggregate of 625 shares acquired under the 2018 Employee Stock Purchase Plan. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 02:00 UTC |
Houston John GDirector · President and CEO
|
Exercise / conversionCommon Stock | 17,510 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-009196 · doc4.xml · nonDerivative · entry 4 Houston John G · CIK 0001753537 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 835,758 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. F4 · balance_after: Includes an aggregate of 625 shares acquired under the 2018 Employee Stock Purchase Plan. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:04 UTC |
Taylor IanChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 68,000 | $0.00 Strike: $78.30 | $0.00 |
DisclosureSEC source: 0000899243-21-009202 · doc4.xml · derivative · entry 3 Taylor Ian · CIK 0001753281 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 68,000 shares Expires 2031-02-25 F4 · derivative.exercise_date: This option award was granted on February 26, 2021. 1/4 of the shares underlying the award shall vest on February 26, 2022, with the remainder of the shares vesting in equal monthly installments following February 26, 2022 through February 26, 2025. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:02 UTC |
Cassidy Sean AChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 68,000 | $0.00 Strike: $78.30 | $0.00 |
DisclosureSEC source: 0000899243-21-009199 · doc4.xml · derivative · entry 3 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 68,000 shares Expires 2031-02-25 F4 · derivative.exercise_date: This option award was granted on February 26, 2021. 1/4 of the shares underlying the award shall vest on February 26, 2022, with the remainder of the shares vesting in equal monthly installments following February 26, 2022 through February 26, 2025. Read SEC document |
| February 26, 2021 Filed Mar 3, 2021 02:04 UTC |
Peck RonaldChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 68,000 | $0.00 Strike: $78.30 | $0.00 |
DisclosureSEC source: 0000899243-21-009203 · doc4.xml · derivative · entry 1 Peck Ronald · CIK 0001783868 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 68,000 shares Expires 2031-02-25 F1 · derivative.exercise_date: This option award was granted on February 26, 2021. 1/4 of the shares underlying the award shall vest on February 26, 2022, with the remainder of the shares vesting in equal monthly installments following February 26, 2022 through February 26, 2025. Read SEC document |
| February 26, 2021 Filed Mar 3, 2021 02:00 UTC |
Houston John GDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 219,500 | $0.00 Strike: $78.30 | $0.00 |
DisclosureSEC source: 0000899243-21-009196 · doc4.xml · derivative · entry 6 Houston John G · CIK 0001753537 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 219,500 shares Expires 2031-02-25 F8 · derivative.exercise_date: This option award was granted on February 26, 2021. 1/4 of the shares underlying the award shall vest on February 26, 2022, with the remainder of the shares vesting in equal monthly installments following February 26, 2022 through February 26, 2025. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 18:09 UTC |
Taylor IanChief Scientific Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,315 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013363 · doc4.xml · derivative · entry 4 Taylor Ian · CIK 0001753281 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,345 Underlying: Common Stock · 3,315 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 18:09 UTC |
Taylor IanChief Scientific Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,437 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013363 · doc4.xml · derivative · entry 3 Taylor Ian · CIK 0001753281 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,211 Underlying: Common Stock · 2,437 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of June 1, 2017, with the remainder of the shares vesting in equal monthly installments following June 1, 2017 through June 1, 2020. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 18:09 UTC |
Taylor IanChief Scientific Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 704 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013363 · doc4.xml · derivative · entry 2 Taylor Ian · CIK 0001753281 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 596 Underlying: Common Stock · 704 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 18:09 UTC |
Taylor IanChief Scientific Officer
|
Exercise / conversionCommon Stock | 6,456 | $16.00 | $103,296.00 |
DisclosureSEC source: 0001209191-21-013363 · doc4.xml · nonDerivative · entry 1 Taylor Ian · CIK 0001753281 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 17:16 UTC |
Cassidy Sean AChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 569 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-21-007149 · doc4.xml · derivative · entry 4 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,127 Underlying: Common Stock · 569 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022. F2 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of June 28, 2019, with the remainder of the shares vesting in equal monthly installments following June 28, 2019 through June 28, 2022. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 17:16 UTC |
Cassidy Sean AChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 325 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-21-007149 · doc4.xml · derivative · entry 3 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,192 Underlying: Common Stock · 325 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022. F1 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 17:16 UTC |
Cassidy Sean AChief Financial Officer
|
Exercise / conversionCommon Stock | 569 | $16.00 | $9,104.00 |
DisclosureSEC source: 0000899243-21-007149 · doc4.xml · nonDerivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,678 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 17:16 UTC |
Cassidy Sean AChief Financial Officer
|
Exercise / conversionCommon Stock | 325 | $16.00 | $5,200.00 |
DisclosureSEC source: 0000899243-21-007149 · doc4.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,109 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:09 UTC |
Cassidy Sean AChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 35,144 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-21-007141 · doc4.xml · derivative · entry 12 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,262 Underlying: Common Stock · 35,144 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. F12 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested on March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:09 UTC |
Cassidy Sean AChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,815 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-21-007141 · doc4.xml · derivative · entry 11 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,815 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. F11 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2017 and the remainder of the shares vested in equal monthly installments following January 1, 2017 through January 1, 2020. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:09 UTC |
Cassidy Sean AChief Financial Officer
|
SaleCommon Stock | 30 | $80.43 | $2,413.04 |
DisclosureSEC source: 0000899243-21-007141 · doc4.xml · nonDerivative · entry 10 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,784 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.42 to $80.86, inclusive. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:09 UTC |
Cassidy Sean AChief Financial Officer
|
SaleCommon Stock | 1,161 | $79.42 | $92,211.26 |
DisclosureSEC source: 0000899243-21-007141 · doc4.xml · nonDerivative · entry 9 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,814 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.10 to $79.91, inclusive. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:09 UTC |
Cassidy Sean AChief Financial Officer
|
SaleCommon Stock | 6,160 | $78.65 | $484,462.44 |
DisclosureSEC source: 0000899243-21-007141 · doc4.xml · nonDerivative · entry 8 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,975 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.09 to $79.07, inclusive. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:09 UTC |
Cassidy Sean AChief Financial Officer
|
SaleCommon Stock | 2,793 | $77.62 | $216,794.62 |
DisclosureSEC source: 0000899243-21-007141 · doc4.xml · nonDerivative · entry 7 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,135 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.05 to $78.04, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.